Background: There was limited evidence on the clinical benefits of the concomitant Cox-Maze procedure with aortic valve replacement (AVR) in patients with atrial fibrillation. This study aimed to ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aortic stenosis without ...

Women undergoing non-mitral cardiac surgeries—specifically CABG or aortic valve replacement—are less likely than their male counterparts to receive guideline-recommended concomitant procedures to ...